BCG vaccination in South African HIV-exposed infants – risks and benefits

Παρόμοια τεκμήρια

• Disseminated bacille Calmette–Guérin disease in HIV-infected South African infants
  ανά: Hesseling, AC, κ.ά.
  Έκδοση: (2009)
• Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination
  ανά: Hesseling, A. C., κ.ά.
  Έκδοση: (2015)
• T Cell Activation in South African HIV-Exposed Infants Correlates with Ochratoxin A Exposure
  ανά: Lianna Frances Wood, κ.ά.
  Έκδοση: (2017-12-01)
• BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial
  ανά: Gasper, Melanie A., κ.ά.
  Έκδοση: (2017)
• Delaying BCG Vaccination Until 8 Weeks of Age Results in Robust BCG-Specific T-Cell Responses in HIV-Exposed Infants
  ανά: Tchakoute, Christophe Toukam, κ.ά.
  Έκδοση: (2015)